Gardiner Harris’s investigation of Johnson & Johnson explores the many ways corporate greed and weak regulations fail to ...

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

The U.S. Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) have announced actions to phase out ...

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

The move would trigger an overhaul of scores of products on U.S. grocery store shelves. The plan was announced Tuesday ...

Miami-based Fruselva issued the recall in March for Target’s Good & Gather Baby Pea, Zucchini, Kale & Thyme Vegetable Puree, ...

J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.

(Reuters) -Johnson & Johnson Chief ... companies should work with the Trump administration to mitigate supply chain vulnerabilities and prevent any drug shortages that can result from tariffs.

The chief executive of Johnson & Johnson has warned that potential ... wide-ranging tariffs announced this month, but the Trump administration has made it clear that it is considering using ...